Article
Heart development in fibronectin-null mice is governed by a genetic modifier on chromosome four.
Howard Hughes Medical Institute, Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
Mechanisms of Development (impact factor:
2.83).
09/2007;
124(7-8):551-8.
DOI:10.1016/j.mod.2007.05.004
pp.551-8
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: New insights into form and function of fibronectin splice variants.
[show abstract] [hide abstract]
ABSTRACT: The extracellular matrix (ECM) is a highly dynamic structure that not only provides a physical framework for cells within connective tissues, but also imparts instructive signals for development, tissue homeostasis and basic cell functions through its composition and ability to exert mechanical forces. The ECM of tissues is composed of, in addition to proteoglycans and hyaluronic acid, a number of proteins, most of which are generated after alternative splicing of their pre-mRNA. However, the precise function of these protein isoforms is still obscure in most cases. Fibronectin (FN), one of the main components of the ECM, is also one of the best-known examples of a family of proteins generated by alternative splicing, having at least 20 different isoforms in humans. Over the last few years, considerable progress on elucidating the functions of the alternatively spliced FN isoforms has been achieved with the essential development of key engineered mouse strains. Here we summarize the phenotypes of the mouse strains having targeted mutations in the FN gene, which may lead to novel insights linking function of alternatively spliced isoforms of fibronectin to human pathologies.The Journal of Pathology 10/2008; 216(1):1-14. · 6.32 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
1-Mbp interval
129S4 FN-null embryos
anterior bilateral positions
C57BL/6J genetic background
cardiac development
cardiac development progresses
centrally
different stages
differentially
embryonic heart formation
embryonic lethality
genes
genetic background
haplotype analyses
heart development
Microarray analysis
molecular underpinning
novel modifier
potential modifiers
severe cardiovascular defects
Sophie Astrof |